SEC Contract Filing

Filing Date: 2025-04-22

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d186990dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SEPARATION AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Separation Agreement (this &#147;<B>Agreement</B>&#148;) is effective as of the 22<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> day of April, 2025 (the &#147;<B>Effective Date</B>&#148;), by and between Tom Langan
(&#147;<B>Executive</B>&#148;) and Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc., a corporation organized and existing under the laws of the State of Delaware (&#147;<B>Company</B>&#148;). Terms used in this Agreement but
not specifically defined herein shall have the same meaning as in the Employment Agreement (defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Company and
Executive entered into an Employment Agreement effective February&nbsp;13, 2018 (the &#147;<B>Employment Agreement</B>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Company and Executive desire to set forth the terms of Executive&#146;s termination of employment, severance benefits, and other
matters related thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing premises, of the mutual agreements and covenants contained
herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Termination Date</U>. As of the close of business on July&nbsp;31, 2025 (the &#147;<B>Termination
Date</B>&#148;), Executive&#146;s employment with, and service as an officer of Company is terminated. As of the Termination Date, Executive irrevocably resigns from all other positions he has with, and boards of directors (and any committees
thereof) of, Company and any subsidiaries and affiliated companies of Company. Notwithstanding the foregoing, if, prior to the Termination Date, the Company hires a new Chief Executive Officer (the &#147;New CEO&#148;), then Executive shall provide
assistance as reasonably required to transition Executive&#146;s duties to the New CEO between the New CEO&#146;s start date and the Termination Date. By providing such transition assistance, Executive shall continue to be eligible for the pay and
benefits described in Section&nbsp;4 of this Agreement upon the Termination Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Performance Through the Termination Date</U>. Executive agrees to continue to materially perform
Executive&#146;s duties and responsibilities as the Interim Chief Executive Officer of the Company at a level of engagement materially similar to the level of engagement as of the Effective Date, as determined in the reasonable discretion of the
Board of Directors of the Company (the &#147;Board&#148;), from the Effective Date through the Termination Date, including, but not limited to, continuing to report to the Board during such time as reasonably warranted in the performance of his
duties and on the same basis as prior to the Effective Date. If the Board determines in its reasonable discretion that Executive is not materially performing his duties as set forth above, then the Board shall immediately notify Executive in writing
detailing any such <FONT STYLE="white-space:nowrap">non-performance,</FONT> and Executive shall have 10 days to cure any such <FONT STYLE="white-space:nowrap">non-performance.</FONT> If Executive fails to cure such
<FONT STYLE="white-space:nowrap">non-performance,</FONT> then the Board may determine that the Termination Date will occur prior to July&nbsp;31, 2025. If the Board does make such a determination, then (a)&nbsp;the
<FONT STYLE="white-space:nowrap">pro-rata</FONT> annual bonus payment described in Section&nbsp;4b will be reduced to reflect the actual Termination Date; and (b)&nbsp;the accelerated equity vesting described in Section&nbsp;4d will be determined as
if Executive had remained continuously employed through the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Termination Date instead of the <FONT STYLE="white-space:nowrap">two-year</FONT> anniversary of the Termination Date.
</P></TD></TR></TABLE>
</DIV></Center>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE